bisindolylmaleimide i has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, JF | 1 |
| Brügger, D | 1 |
| Brischwein, K | 1 |
| Liu, C | 1 |
| Bader, P | 1 |
| Niethammer, D | 1 |
| Gekeler, V | 1 |
1 other study available for bisindolylmaleimide i and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; DNA-Bind | 2001 |